NLRP3 inflammasome activation, such as IL-1β and IL-18 production, promotes immune cell infiltration in the tumor microenvironment and enhances chemotherapy-induced anti-tumor immunity [218, 219]. This evidence concerns the gene IL18 and neoplasm.